Ovarian cancer accounts for approximately 25% of gynecological cancers in women, but
over 50% of deaths. Current treatments rarely result in long-term cure. This study will focus on an approach taken by gene therapy known as immunotherapy. Cancer cells are not recognized by the body's immune system because they are not foreign, rather mutations of existing cells. The intent of immunotherapy is to induce the individuals immune system to recognize cancer cells as if they are foreign, and thus a threat, so that these cells are destroyed.

< Return to list of ACGT Fellows